Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Wilson

Showing results (241-250 of 424) with videos related to

Pageof 43
Sort By:
Metabolism: Clinical and Experimental|October 23, 2009
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humansMarie-France Hivert, Lisa M Sullivan, Peter Shrader, et al.
Circulation|December 29, 2005
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart StudySekar Kathiresan, James D Otvos, Lisa M Sullivan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2008
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetesAyad A Jaffa, William R Usinger, M Brent McHenry, et al.
Diabetes Care|February 28, 2009
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trialItamar Raz, Peter W F Wilson, Krzysztof Strojek, et al.
Plos One|April 4, 2012
Framingham risk score and alternatives for prediction of coronary heart disease in older adultsNicolas Rodondi, Isabella Locatelli, Drahomir Aujesky, et al.
International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
American Journal of Epidemiology|March 9, 2004
Metacarpal cortical area and risk of coronary heart disease: the Framingham StudyElizabeth J Samelson, Douglas P Kiel, Kerry E Broe, et al.
Plos One|July 20, 2019
Random plasma glucose predicts the diagnosis of diabetesMary K Rhee, Yuk-Lam Ho, Sridharan Raghavan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham StudyJohn F Keaney, Martin G Larson, Ramachandran S Vasan, et al.
Circulation|March 26, 2003
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart StudyRamachandran S Vasan, Lisa M Sullivan, Ronenn Roubenoff, et al.
Pageof 43

Showing results (241-250 of 424) with videos related to

Sort By:
Pageof 43
Metabolism: Clinical and Experimental|October 23, 2009
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humansMarie-France Hivert, Lisa M Sullivan, Peter Shrader, et al.
Circulation|December 29, 2005
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart StudySekar Kathiresan, James D Otvos, Lisa M Sullivan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2008
Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetesAyad A Jaffa, William R Usinger, M Brent McHenry, et al.
Diabetes Care|February 28, 2009
Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trialItamar Raz, Peter W F Wilson, Krzysztof Strojek, et al.
Plos One|April 4, 2012
Framingham risk score and alternatives for prediction of coronary heart disease in older adultsNicolas Rodondi, Isabella Locatelli, Drahomir Aujesky, et al.
International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
American Journal of Epidemiology|March 9, 2004
Metacarpal cortical area and risk of coronary heart disease: the Framingham StudyElizabeth J Samelson, Douglas P Kiel, Kerry E Broe, et al.
Plos One|July 20, 2019
Random plasma glucose predicts the diagnosis of diabetesMary K Rhee, Yuk-Lam Ho, Sridharan Raghavan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham StudyJohn F Keaney, Martin G Larson, Ramachandran S Vasan, et al.
Circulation|March 26, 2003
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart StudyRamachandran S Vasan, Lisa M Sullivan, Ronenn Roubenoff, et al.
Pageof 43